Nine things to know about anticoagulants
Different patients will need different anticoagulants, say clinical pharmacologists Paul Chin and Matthew Dooge.
Key considerations should include patient adherence, kidney and liver function, and potential interactions with other drugs. Dosing should accommodate these factors, they write in Australian Prescriber.
Regardless of whether the drug prescribed is warfarin or one of the non-vitamin K antagonists, more commonly known as new oral anticoagulants (NOACs), patients should be regularly monitored for bleeding, adherence to treatment, changing comorbidities and